Recruiting

Ultrasound-guided Dry Needling

Sponsor:

Texas Tech University Health Sciences Center

Code:

NCT07309874

Conditions

Headache Disorders, Primary

Headache, Cervicogenic

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Dry needling

Study Details

Brief summary:

Headaches such as tension-type, migraine, and cervicogenic (neck-related) headaches are among the most common and disabling conditions worldwide. and are often associated with tight or sensitive muscles at the base of the skull, which can contribute to headaches. Dry needling involves inserting a very thin, sterile needle into tight muscle areas known as trigger points to relieve pain and muscle tension. When applied to the deep neck muscles, including those beneath the skull, dry needling may reduce headache symptoms. The suboccipital region contains important structures such as the vertebral artery, greater occipital nerve, and spinal cord, which requires precise needle placement to maintain safety. Many needling techniques used in this region have not been validated for accuracy or safety in living subjects. This study will use real-time ultrasound imaging to guide dry needling of the rectus capitis posterior major muscle and directly visualize nearby structures to minimize risk.

The main goals of this research are to examine the effects of a single session of ultrasound-guided dry needling on headache symptoms and to confirm the safety, accuracy, and consistency of the proposed needling technique using ultrasound imaging.

Conditions

Headache Disorders, Primary

Headache, Cervicogenic

Study ID

NCT07309874

Start date

Mar 1, 2026

Status verified date

Sep, 2026

Completion date

Mar 1, 2027

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Reports of a headache within the last 6 months (no minimum or maximum frequency or duration)
  • Current reports of headache
  • Tenderness to palpation of suboccipital muscles with Numeric Pain Rating Scale score ≥ 2/10
  • No history of cervical spine surgery or neurological disorders

Exclusion Criteria:

  • History of cervical spine trauma or surgery
  • Diagnosed bleeding disorder
  • Currently using anticoagulant medications
  • Currently using anti-platelet medications
  • Diagnosed systemic joint diseases such as rheumatoid arthritis
  • Active infection
  • Diabetes
  • Cancer
  • Fibromyalgia
  • Cervical radiculopathy
  • Inability to tolerate prone positioning for the duration of the procedure.

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Dry needling

Interventions

Dry needling

Each subject will receive two separate dry needle insertions targeting the rectus capitus posterior major. Method 1 will be 30 degrees (relative to the frontal plane) insertion angle toward the occiput. Method 2 will be 45 degrees (relative to the frontal plane) insertion angle toward the occiput.

Primary outcome measure

  • Post-needling soreness [ Time Frame: 24-48 hours post-data collection ]
  • Numeric Pain Rating Scale [ Time Frame: Baseline immediately pre-data collection and then again 24-48 hours post-data collection ]
  • Headache Disability Index [ Time Frame: Baseline immediately pre-data collection and then again 24-48 hours post-data collection ]

Central Contacts and Locations

Central contacts

Jace A Brown, PT, PhD

9406897716jbrown34@twu.edu

Locations

Texas Tech University Health Sciences Center

Recruiting

Lubbock, Texas, United States, 79430-0001

Contacts

More Information

Sponsor

Texas Tech University Health Sciences Center

Last update posted

Sep 9, 2026

Last verified

Sep, 2026

Keywords

  • Headache
  • cervical spine
  • suboccipital muscles
  • needle placement

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Texas Tech University Health Sciences Center on 2026-09-09.